Parmax Pharma Limited (BOM:540359)
India · Delayed Price · Currency is INR 120.10
+2.35 (2.00%)
At close: Aug 17, 2026
Parmax Pharma Market Cap
Parmax Pharma has a market cap or net worth of 449.33 million as of August 17, 2026. Its market cap has increased by 211.62% in one year.
Market Cap
449.33M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
120.10
ChartMarket Cap Chart
Since July 26, 2019, Parmax Pharma's market cap has increased from 67.90M to 449.33M, an increase of 561.71%. That is a compound annual growth rate of 30.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 449.33M | 255.01% |
| Dec 31, 2025 | 126.57M | -23.55% |
| Dec 31, 2024 | 165.55M | 35.86% |
| Dec 29, 2023 | 121.85M | -15.84% |
| Dec 30, 2022 | 144.79M | -35.45% |
| Dec 31, 2021 | 224.29M | 103.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biofil Chemicals and Pharmaceuticals | 531.18M |
| Phaarmasia | 525.74M |
| Mangalam Drugs & Organics | 450.31M |
| JFL Life Sciences | 435.54M |
| Shelter Pharma | 424.29M |
| Vista Pharmaceuticals | 424.09M |
| Rajnish Wellness | 416.29M |
| ANG Lifesciences India | 410.29M |